As the antagonistic pathways NF-κB and p53 predominantly modulate inflammation in synovial fibroblasts in the context of rheumatoid arthritis [26,29], RT-qPCR experiments were carried out to assess the expression of these two transcription factors. The gene discussed is TP53; the disease is rheumatoid arthritis.